| Source: |
| Type: |
| Drug dosage vs efficacy, and actual dosage number of research papers. |
| 3539- | ALA, | Alpha-lipoic acid as a dietary supplement: Molecular mechanisms and therapeutic potential |
| - | Review, | AD, | NA |
| 281- | ALA, | Reactive oxygen species mediate caspase activation and apoptosis induced by lipoic acid in human lung epithelial cancer cells through Bcl-2 down-regulation |
| - | in-vitro, | Lung, | H460 |
| 304- | ALA, | alpha-Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2-*-generation |
| - | in-vitro, | Colon, | HT-29 |
| 267- | ALA, | α-Lipoic Acid Targeting PDK1/NRF2 Axis Contributes to the Apoptosis Effect of Lung Cancer Cells |
| - | vitro+vivo, | Lung, | A549 | - | vitro+vivo, | Lung, | PC9 |
| 5320- | ALC, | l-Carnitine: An adequate supplement for a multi-targeted anti-wasting therapy in cancer |
| - | in-vivo, | Var, | NA |
| 5324- | ALC, | The anti-wasting effects of L-carnitine supplementation on cancer: experimental data and clinical studies |
| - | Review, | Var, | NA |
| 5321- | ALC, | L-Carnitine |
| - | Review, | Var, | NA |
| 5319- | ALC, | l-carnitine and cancer cachexia: Clinical and experimental aspects |
| - | Review, | Var, | NA |
| 3974- | ALC, | Carnitine |
| - | Review, | AD, | NA |
| - | Trial, | NSCLC, | NA |
| 5360- | almon, | BEV, | Case report: Almonertinib in combination with bevacizumab for leptomeningeal metastases from epidermal growth factor receptor-mutation non-small cell lung cancer: Case series |
| - | Case Report, | NSCLC, | NA |
| - | Trial, | HNSCC, | NA |
| 7397- | Amla, | Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study |
| - | Trial, | Nor, | NA |
| 7399- | Amla, | Molecular Mechanisms of Cancer Prevention by Gooseberry (Phyllanthus emblica) |
| - | Review, | Var, | NA |
| 7401- | Amla, | The impact of Emblica Officinalis (Amla) on lipid profile, glucose, and C-reactive protein: A systematic review and meta-analysis of randomized controlled trials |
| - | Review, | Nor, | NA |
| 7402- | Amla, | Traditional knowledge to clinical trials: A review on therapeutic actions of Emblica officinalis |
| - | Review, | Var, | NA |
| 7393- | Amla, | Emblica officinalis extract induces autophagy and inhibits human ovarian cancer cell proliferation, angiogenesis, growth of mouse xenograft tumors |
| - | vitro+vivo, | Ovarian, | OVCAR-3 | - | in-vitro, | Ovarian, | SW626 |
| 7407- | Amla, | Functional and Nutraceutical Significance of Amla (Phyllanthus emblica L.): A Review |
| - | Review, | Nor, | NA |
| 7408- | Amla, | Fresh Phyllanthus emblica (Amla) Fruit Supplementation Enhances Milk Fatty Acid Profiles and the Antioxidant Capacities of Milk and Blood in Dairy Cows |
| - | Trial, | Nor, | NA |
| 7409- | Amla, | Clinical evaluation of Emblica Officinalis Gatertn (Amla) in healthy human subjects: Health benefits and safety results from a randomized, double-blind, crossover placebo-controlled study |
| - | Trial, | Nor, | NA |
| 6594- | Anamu, | Dibenzyl trisulfide induces caspase-independent death and lysosomal membrane permeabilization of triple-negative breast cancer cells |
| - | in-vitro, | BC, | HCC1806/CRL-2335 | - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MDA-MB-468 |
| 6599- | Anamu, | Potential behavioral and pro-oxidant effects of Petiveria alliacea L. extract in adult rats |
| 6402- | ANE, | FEO, | trans-Anethole of Fennel Oil is a Selective and Nonelectrophilic Agonist of the TRPA1 Ion Channel |
| - | in-vitro, | Nor, | HEK293 |
| 6887- | Ang, | Medicinal properties of Angelica archangelica root extract: Cytotoxicity in breast cancer cells and its protective effects against in vivo tumor development |
| - | in-vivo, | BC, | 4T1 | - | in-vitro, | BC, | MCF7 |
| 4765- | antiOx, | Chemo, | Antioxidants as precision weapons in war against cancer chemotherapy induced toxicity – Exploring the armoury of obscurity |
| - | Review, | Var, | NA |
| 7839- | AO, | ISQ, | The Protective Effects of Acer okamotoanum and Isoquercitrin on Obesity and Amyloidosis in a Mouse Model |
| - | in-vivo, | AD, | NA | - | in-vivo, | Obesity, | NA |
| 3887- | Api, | The flavonoid apigenin protects brain neurovascular coupling against amyloid-β₂₅₋₃₅-induced toxicity in mice |
| - | in-vivo, | AD, | NA |
| 2635- | Api, | CUR, | Synergistic Effect of Apigenin and Curcumin on Apoptosis, Paraptosis and Autophagy-related Cell Death in HeLa Cells |
| - | in-vitro, | Cerv, | HeLa |
| 1152- | Api, | Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers? |
| - | Analysis, | Nor, | NA |
| 1556- | Api, | Dissolution and antioxidant potential of apigenin self nanoemulsifying drug delivery system (SNEDDS) for oral delivery |
| - | Analysis, | NA, | NA |
| 1555- | Api, | USDA Database for the Flavonoid Content of Selected Foods |
| - | Analysis, | NA, | NA |
| 1553- | Api, | Role of Apigenin in Cancer Prevention via the Induction of Apoptosis and Autophagy |
| - | Review, | NA, | NA |
| 1548- | Api, | A comprehensive view on the apigenin impact on colorectal cancer: Focusing on cellular and molecular mechanisms |
| - | Review, | Colon, | NA |
| 1547- | Api, | Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading |
| - | Review, | NA, | NA |
| 1544- | Api, | The flavone apigenin blocks nuclear translocation of sterol regulatory element-binding protein-2 in the hepatic cells WRL-68 |
| - | in-vitro, | Nor, | WRL68 |
| 1543- | Api, | Therapeutical properties of apigenin: a review on the experimental evidence and basic mechanisms |
| - | Review, | NA, | NA |
| 1541- | Api, | EGCG, | Prospective cohort comparison of flavonoid treatment in patients with resected colorectal cancer to prevent recurrence |
| - | Human, | NA, | NA |
| 1559- | Api, | Dually Active Apigenin-Loaded Nanostructured Lipid Carriers for Cancer Treatment |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | BC, | MDA-MB-231 |
| 1563- | Api, | MET, | Metformin-induced ROS upregulation as amplified by apigenin causes profound anticancer activity while sparing normal cells |
| - | in-vitro, | Nor, | HDFa | - | in-vitro, | PC, | AsPC-1 | - | in-vitro, | PC, | MIA PaCa-2 | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | LNCaP | - | in-vivo, | NA, | NA |
| 3819- | Aroma, | Aromatherapy improves cognitive dysfunction in senescence-accelerated mouse prone 8 by reducing the level of amyloid beta and tau phosphorylation |
| - | Human, | AD, | NA | - | in-vitro, | AD, | NA |
| 5382- | ART/DHA, | A phase I study of intravenous artesunate in patients with advanced solid tumor malignancies |
| - | Trial, | Var, | NA |
| 2569- | ART/DHA, | A semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction |
| - | Human, | Nor, | NA |
| 2578- | ART/DHA, | RES, | Synergic effects of artemisinin and resveratrol in cancer cells |
| - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Cerv, | HeLa |
| 5415- | ASA, | The Anti-Metastatic Role of Aspirin in Cancer: A Systematic Review |
| - | Review, | Var, | NA |
| 5410- | ASA, | Low-Dose Aspirin and the Prevention of Colorectal Cancer in Inflammatory Bowel Disease: A Nationwide Cohort Study |
| - | Study, | CRC, | NA |
| 5404- | ASA, | Low-Dose Aspirin and Prevention of Colorectal Cancer: Evidence From a Nationwide Registry-Based Cohort in Norway |
| - | Study, | CRC, | NA |
| 5406- | ASA, | Adjuvant aspirin therapy and colorectal cancer survival |
| - | Trial, | CRC, | NA |
| 5407- | ASA, | Low-dose aspirin reduces the risk of colorectal cancer recurrence in patients with resected PI3K-altered localised disease, according to the ALASCCA trial. |
| - | Trial, | CRC, | NA |
| 5396- | Ash, | Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology |
| - | Review, | Var, | NA |
| 3155- | Ash, | Overview of the anticancer activity of withaferin A, an active constituent of the Indian ginseng Withania somnifera |
| - | Review, | Var, | NA |
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1114 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid